|
|
||||||||
Investigative Ophthalmology & Visual Science, Vol 34, 2055-2061, Copyright © 1993 by Association for Research in Vision and Ophthalmology
ARTICLES AND REPORTS |
SF Hackett and PA Campochiaro
Wilmer Institute, Johns Hopkins Hospital, Baltimore, Maryland 21205.
PURPOSE. To examine the effect of several agents that either stimulate or inhibit neovascularization on plasminogen activator inhibitor-1 and urokinase in retinal pigmented epithelial cells and vascular endothelial cells. METHODS. Steady-state levels of messenger RNA were assessed by Northern blots and dot blots and protein levels were assessed by immunoprecipitation. RESULTS. Data indicate that messenger RNA levels for plasminogen activator inhibitor-1 are modulated in similar fashion in both cells types, being increased by incubation with transforming growth factor-beta, dexamethasone, tumor necrosis factor, phorbol myristate acetate, and thrombin. Levels of urokinase messenger RNA in retinal pigmented epithelial cells are significantly increased only by phorbol myristate acetate and are decreased by dexamethasone and transforming growth factor-beta, whereas in endothelial cells plasminogen activator urokinase messenger RNA is increased by each of the stimuli except dexamethasone, which causes a decrease. Immunoprecipitation experiments demonstrate similar modulation of inhibitor-1 proteins secreted by retinal pigmented epithelial cells, whereas urokinase is difficult to detect. CONCLUSIONS. These data suggest that retinal pigmented epithelial cells may help to alter proteolytic activity in the subretinal space and thereby participate, along with endothelial cells, in the regulation of choroidal neovascularization.
This article has been cited by other articles:
![]() |
A. Londesborough, K. Vaahtomeri, M. Tiainen, P. Katajisto, N. Ekman, T. Vallenius, and T. P. Makela LKB1 in endothelial cells is required for angiogenesis and TGF{beta}-mediated vascular smooth muscle cell recruitment Development, July 1, 2008; 135(13): 2331 - 2338. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Koh, K. Bessho, L. Cheng, D.-U. Bartsch, T. R. Jones, G. Bergeron-Lynn, and W. R. Freeman Inhibition of Choroidal Neovascularization in Rats by the Urokinase-Derived Peptide A6 Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 635 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Rakic, V. Lambert, C. Munaut, K. Bajou, K. Peyrollier, M.-L. Alvarez-Gonzalez, P. Carmeliet, J.-M. Foidart, and A. Noel Mice without uPA, tPA, or Plasminogen Genes Are Resistant to Experimental Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1732 - 1739. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Schacke, K.-F. Beck, J. Pfeilschifter, F. Koch, and L.-O. Hattenbach Modulation of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 by Transforming Growth Factor-{beta} in Human Retinal Glial Cells Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2799 - 2805. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Masos, J. A. Dan, and R. Miskin Plasminogen Activator Inhibitor-1 mRNA Is Localized in the Ciliary Epithelium of the Rodent Eye Invest. Ophthalmol. Vis. Sci., April 1, 2000; 41(5): 1006 - 1011. [Abstract] [Full Text] |
||||
![]() |
P. Campochiaro, S. Hackett, S. Vinores, J Freund, C Csaky, W LaRochelle, J Henderer, M Johnson, I. Rodriguez, Z Friedman, et al. Platelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epithelial cells J. Cell Sci., January 9, 1994; 107(9): 2459 - 2469. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |